• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Bio-Rad Laboratories Inc.

    11/6/25 4:24:39 PM ET
    $BIO.B
    Get the next $BIO.B alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0002022345
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    BIO-RAD LABORATORIES, INC.
    SEC File Number
    001-07928
    Address of Issuer
    1000 ALFRED NOBEL DRIVE
    HERCULES
    CALIFORNIA
    94547
    Phone
    510-724-7000
    Name of Person for Whose Account the Securities are To Be Sold
    JAMES BARRY
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    701214633.082190639911/06/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common09/06/2025Restricted StockIssuerCheckbox not checked21409/06/2025Not Applicable
    Common09/01/2025Restricted StockIssuerCheckbox not checked38509/01/2025Not Applicable
    Common09/03/2024Restricted StockIssuerCheckbox not checked7009/03/2024Not Applicable
    Common03/28/2024Employee Stock Purchase PlanIssuerCheckbox not checked2903/28/2024Cash
    Common12/29/2023Employee Stock Purchase PlanIssuerCheckbox not checked312/29/2023Cash

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    11/06/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/James Barry

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $BIO.B alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIO.B

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BIO.B
    SEC Filings

    View All

    SEC Form 144 filed by Bio-Rad Laboratories Inc.

    144 - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/6/25 4:24:39 PM ET
    $BIO.B

    SEC Form 10-Q filed by Bio-Rad Laboratories Inc.

    10-Q - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

    10/29/25 4:18:31 PM ET
    $BIO.B

    Bio-Rad Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

    10/29/25 4:16:49 PM ET
    $BIO.B

    $BIO.B
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits

    SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostic products, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer. The Element AVITI Sequencing Platform's novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuo

    2/8/23 8:00:00 AM ET
    $BIO
    $BIO.B
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BIO.B
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, President, LSG Barry James sold $214,289 worth of Bio-Rad A Common Stock (700 units at $306.18), decreasing direct ownership by 58% to 510 units (SEC Form 4)

    4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

    11/10/25 4:15:49 PM ET
    $BIO.B

    President & COO Divincenzo Jonathan P. converted options into 1,869 units of Bio-Rad A Common Stock and covered exercise/tax liability with 950 units of Bio-Rad A Common Stock (SEC Form 4)

    4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

    10/28/25 12:29:44 PM ET
    $BIO.B

    EVP, Global Supply Chain Evran Sedat converted options into 1,044 units of Bio-Rad A Common Stock and covered exercise/tax liability with 335 units of Bio-Rad A Common Stock, increasing direct ownership by 47% to 2,233 units (SEC Form 4)

    4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

    10/21/25 4:42:00 PM ET
    $BIO.B

    $BIO.B
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Bio-Rad Laboratories Inc.

    SC 13G - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/14/24 5:25:27 PM ET
    $BIO.B

    Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

    SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/12/24 1:27:07 PM ET
    $BIO.B

    Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

    SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/4/24 11:22:04 AM ET
    $BIO.B